David Delfassy

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia.

The Kennedy Trust for Rheumatology Research is a British research-focused company that was founded in 1969. The non-profit company is based in London, UK. The Kennedy Trust supports research into rheumatic and related musculoskeletal diseases.

Bit Bio Ltd. engages in research and experimental development on natural sciences and engineering. Its products are human-induced skeletal myocytes and glutamatergic neurons. The company was founded by Mark Kotter in 2016 and is headquartered in Cambridge, the United Kingdom.

MRC Laboratory of Molecular Biology provides biological research and development services. it also offers methods for determining the three-dimensional structures of proteins and other macromolecules, the sequencing of DNA and the development of monoclonal antibodies. The company was founded by Max Ferdinand Perutz in 1962 and is headquartered in Cambridge, the United Kingdom.

Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK.

MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK.

The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

The Minerva Institute for Research & Scholarship engages in facilitating the administration of grant-funded research, and advocating for broad reform in higher education. The company is headquartered in San Francisco, CA.

AKO Capital LLP is the alternative investment management subsidiary of AKO Capital Management Ltd., itself owned by AKO Capital (Jersey) Ltd. in Great Britain. The firm was founded in 2005 by Nicolai Tangen. Headquartered in London, AKO Capital manages the assets of long-term oriented investor base that includes endowments, charitable foundations, institutional investors and sovereign wealth funds.

Appian Capital Advisory LLP (Appian Capital) is an private equity firm founded in 2012 by Michael W. Scherb. The firm is headquartered in London.

Balderton Capital (UK) LLP (Balderton Capital) is an Independent Venture Capital firm founded by Eric Archambeau in 2000. The firm is headquartered in London.

Rose Park Advisors LLC (RPA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Matthew Christensen and Clayton Christensen in 2007. RPA provides investment advisory services to private investment vehicles.

Gresham House Asset Management Ltd. (Gresham House) is a private equity firm, a subsidiary of Gresham House Holdings Ltd. founded in 2000. The firm is headquartered in London, the United Kingdom.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Zoe Global Ltd. is nutritional science company. It helps people eat with confidence. The company was founded by Tim Spector, Jonathan Wolf and George Hadjigeorgiou and is headquartered in London, the United Kingdom.

Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom.

Geometric Intelligence, Inc. develops software application that redefining the boundaries of machine learning. The company was founded in Gary Marcus, Zoubin Ghahramani, Doug Bemis and Ken Stanley and is headquartered in New York, NY.

Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry.

The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom.

Italtel Group SpA engages in the development of Internet protocol based telecommunications products and services. Its products include session border controllers, media gateways and border gateways, IP Multimedia Subsystem core and applications, web based communication, centralized routing and policing, network control and products end of life policy, The company was founded in 1921 and is headquartered in Settimo Milanese, Italy.

Italtel SpA manufactures and markets telecommunication equipment. The firm’s products include web-based communications, SDN monitoring and automation, session border controller, media gateway and border gateway, centralized routing and policy engine, virtual network functions manager, IMS core and applications, customer experience, network control and products end of life policy. Its services include consultancy and engineering, implementation, operation and optimization. The company was founded in 1921 and is headquartered in Settimo Milanese, Italy.

Plus Capital Management LLC (Plus Capital) is a venture Capital firm founded in 2012 by Adam Lilling. The firm is headquartered in Marina del Rey, California.

Clearstone Venture Management Services LLC (Clearstone Venture Partners) is a venture capital firm founded in 1997 by William Elkus. The firm is headquartered in Santa Monica, California.